3,155 research outputs found
Justification by Faith: A Both-And Approach
The Pauline doctrine of justification is a prevailing subject among biblical scholarship today. Especially, as a New Perspective on Pauline literature rises claiming that Luther was wrong in his view of Justification, since he was blinded by his own context forcing it into his interpretation of the Pauline text. Consequently, the reformed view cannot be right since it interprets the doctrine of justification mainly through soteriological lens, whereas the Apostle had only ecclesiological purposes in mind when addressing the subject. In light of the previous thought, the purpose of the article is to criticize the New Perspective’s exclusive method by proposing a “both-end” approach to Justification affirming the soteriological aspects of justification held by Luther, but also pointing out the reality of ecclesiological implications. The article is divided in two main sections. The first section highlights the NPP (New Perspective on Paul) definitions of key terms, such as “Works of the Law”, “the Righteousness of God”, and “Justification”, followed by important observations concerning their view of the terms. The second portion of the article provides three main arguments for Paul’s use of the doctrine of Justification having primarily in mind soteriological purposes. The hope for this work is not to solve the debate between both parties, but to demonstrate that the traditional (reformed) view concerning the doctrine of justification is not absurd, as some would say, and that it is possible to hold a soteriological position and still affirm ecclesiological implications to the Pauline doctrine
Integration of miRNA and mRNA expression profles reveals microRNA-regulated networks during muscle wasting in cardiac cachexia
Cardiac cachexia (CC) is a common complication of heart failure (HF) associated with muscle wasting and poor patient prognosis. Although different mechanisms have been proposed to explain muscle wasting during CC, its pathogenesis is still not understood. Here, we described an integrative analysis between miRNA and mRNA expression profiles of muscle wasting during CC. Global gene expression profiling identified 1,281 genes and 19 miRNAs differentially expressed in muscle wasting during CC. Several of these deregulated genes are known or putative targets of the altered miRNAs, including miR-29a-3p, miR-29b-3p, miR-210-5p, miR-214, and miR-489. Gene ontology analysis on integrative mRNA/miRNA expression profiling data revealed miRNA interactions affecting genes that regulate extra-cellular matrix (ECM) organization, proteasome protein degradation, citric acid cycle and respiratory electron transport. We further identified 11 miRNAs, including miR-29a-3p and miR-29b-3p, which target 21 transcripts encoding the collagen proteins related to ECM organization. Integrative miRNA and mRNA global expression data allowed us to identify miRNA target genes involved in skeletal muscle wasting in CC. Our functional experiments in C2C12 cells confirmed that miR-29b down-regulates collagen genes and contributes to muscle cell atrophy. Collectively, our results suggest that key ECM-associated miRNAs and their target genes may contribute to CC in HF
A perspective of solutions for membrane instabilities in olefin/paraffin separations: a review
Light olefins are mainly produced by naphtha steam cracking, which is among the more energy intensive processes in the petrochemical industry. To save energy, some alternatives have been proposed to partially replace or combine with cryogenic distillation the conventional technology to separate olefins and paraffins. Within this aim, facilitated transport membranes, mainly with Ag+cations as selective carriers, have received great attention owing to the high selectivity and permeance provided. However, to be used industrially, the undesirable instability associated with the Ag+ cation should be considered. Poisonous agents and polymer membrane materials are sources of Ag+ deactivation. In recent years, great achievements on the separation performance have been reported, but the current challenge is to maintain the selectivity in long-term separation processes. This work presents a critical analysis of the potential causes of Ag+ deactivation and points out some alternatives that have been proposed to overcome the hurdle. This review highlights and critically analyses some perspectives of the ongoing development and application of facilitated transport membranes.The authors thank the Brazilian Federal Agency for Support and Evaluation of Graduate Education − CAPES (PDSE Grant 88881.134232/2016-01) and the Spanish Ministry of Economy, Industry and Competitiveness (CTQ2015-66078-R and CTQ2016-75158-R projects, Spain-FEDER 2014-2020) for financial support
MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB–NFIB fusion gene
Breast adenoid cystic carcinoma (AdCC), a rare type of triple-negative breast cancer, has been shown to be driven by MYB pathway activation, most often underpinned by the MYB–NFIB fusion gene. Alternative genetic mechanisms, such as MYBL1 rearrangements, have been reported in MYB–NFIB-negative salivary gland AdCCs. Here we report on the molecular characterization by massively parallel sequencing of four breast AdCCs lacking the MYB–NFIB fusion gene. In two cases, we identified MYBL1 rearrangements (MYBL1–ACTN1 and MYBL1–NFIB), which were associated with MYBL1 overexpression. A third AdCC harboured a high-level MYB amplification, which resulted in MYB overexpression at the mRNA and protein levels. RNA-sequencing and whole-genome sequencing revealed no definite alternative driver in the fourth AdCC studied, despite high levels of MYB expression and the activation of pathways similar to those activated in MYB–NFIB-positive AdCCs. In this case, a deletion encompassing the last intron and part of exon 15 of MYB, including the binding site of ERG-1, a transcription factor that may downregulate MYB, and the exon 15 splice site, was detected. In conclusion, we demonstrate that MYBL1 rearrangements and MYB amplification probably constitute alternative genetic drivers of breast AdCCs, functioning through MYBL1 or MYB overexpression. These observations emphasize that breast AdCCs probably constitute a convergent phenotype, whereby activation of MYB and MYBL1 and their downstream targets can be driven by the MYB–NFIB fusion gene, MYBL1 rearrangements, MYB amplification, or other yet to be identified mechanisms. Copyright © 2017 Pathological Society of Great Britain and Ireland
Histological study of cell migration in the dermis of hamsters after immunisation with two different vaccines against visceral leishmaniasis.
Vaccine candidates, including live and/or killed parasites, Leishmania -purified fractions, defined recombinant antigens and antigen-encoding DNA-plasmids have been proposed to use as vaccine anti- Leishmania . More recently, the hamsters have been used to pre selection of antigens candidate to apply in further experiments using canine model. In this report we evaluated the kinetics of cell migration in dermal inflammatory infiltrate, circulating leukocytes and the presence of nitric oxide (NO)/induced nitric oxide synthase during the early (1?24 h) and late (48?168 h) periods following inoculation of hamsters with antigenic components of anti-canine visceral leishmaniasis vaccines Leishmune 1 and Leishmania braziliensis antigen (LB) with and without saponin (Sap) adjuvant. Our results show that LB caused an early reduction of lymphocytes in the dermis while Sap and LBSap triggered a late recruitment, suggesting the role of the adjuvant in the traffic of antigen-presenting cells and the induction of lymphocyte migration. In that manner our results suggest that the kinetics of cell migration on hamster model may be of value in the selection of vaccine antigens prior the tests in dogs particularly in respect of the toxicity of the preparations
Effectiveness of nano-calcium phosphate paste on sensitivity during and after bleaching: a randomized clinical trial
Immunotherapy and immunochemotherapy in visceral leishmaniasis : promising treatments for this neglected disease.
Leishmaniasis has several clinical forms: self-healing or chronic cutaneous leishmaniasis
or post-kala-azar dermal leishmaniasis; mucosal leishmaniasis; visceral leishmaniasis (VL),
which is fatal if left untreated.The epidemiology and clinical features of VL vary greatly due
to the interaction of multiple factors including parasite strains, vectors, host genetics, and
the environment. Human immunodeficiency virus infection augments the severity of VL
increasing the risk of developing active disease by 100?2320 times. An effective vaccine
for humans is not yet available. Resistance to chemotherapy is a growing problem in many
regions, and the costs associated with drug identification and development, make commercial
production for leishmaniasis, unattractive.The toxicity of currently drugs, their long
treatment course, and limited efficacy are significant concerns. For cutaneous disease,
many studies have shown promising results with immunotherapy/immunochemotherapy,
aimed to modulate and activate the immune response to obtain a therapeutic cure. Nowadays,
the focus of many groups centers on treating canine VL by using vaccines and
immunomodulators with or without chemotherapy. In human disease, the use of cytokines
like interferon-g associated with pentavalent antimonials demonstrated promising results
in patients that did not respond to conventional treatment. In mice, immunomodulation
based on monoclonal antibodies to remove endogenous immunosuppressive cytokines
(interleukin-10) or block their receptors, antigen-pulsed syngeneic dendritic cells, or biological
products like Pam3Cys (TLR ligand) has already been shown as a prospective treatment
of the disease. This review addresses VL treatment, particularly immunotherapy and/or
immunochemotherapy as an alternative to conventional drug treatment in experimental
models, canine VL, and human disease
Azimuthal anisotropy of charged particles at high transverse momenta in PbPb collisions at sqrt(s[NN]) = 2.76 TeV
The azimuthal anisotropy of charged particles in PbPb collisions at
nucleon-nucleon center-of-mass energy of 2.76 TeV is measured with the CMS
detector at the LHC over an extended transverse momentum (pt) range up to
approximately 60 GeV. The data cover both the low-pt region associated with
hydrodynamic flow phenomena and the high-pt region where the anisotropies may
reflect the path-length dependence of parton energy loss in the created medium.
The anisotropy parameter (v2) of the particles is extracted by correlating
charged tracks with respect to the event-plane reconstructed by using the
energy deposited in forward-angle calorimeters. For the six bins of collision
centrality studied, spanning the range of 0-60% most-central events, the
observed v2 values are found to first increase with pt, reaching a maximum
around pt = 3 GeV, and then to gradually decrease to almost zero, with the
decline persisting up to at least pt = 40 GeV over the full centrality range
measured.Comment: Replaced with published version. Added journal reference and DO
Compressed representation of a partially defined integer function over multiple arguments
In OLAP (OnLine Analitical Processing) data are analysed in an n-dimensional cube. The cube may be represented as a partially defined function over n arguments. Considering that often the function is not defined everywhere, we ask: is there a known way of representing the function or the points in which it is defined, in a more compact manner than the trivial one
- …